Wird geladen...
Personalized therapy for lung cancer: striking a moving target
Molecular targeted therapy heralded a new era for the treatment of patients with oncogene-driven advanced-stage non–small-cell lung cancer (NSCLC). Molecular testing at the time of diagnosis guides therapy selection, and targeted therapies in patients with activating mutations in EGFR, BRAF, and rea...
Gespeichert in:
| Veröffentlicht in: | JCI Insight |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Clinical Investigation
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6129126/ https://ncbi.nlm.nih.gov/pubmed/30089719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.120858 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|